Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout
Another day, another delay. On Monday, Roche revealed that in addition to the US Federal Trade Commission, the UK’s Competition and Markets Authority is probing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.